Inflammatory back pain

Česká verzia

Authors: M. Gregová
Authors place of work: Klinika revmatologie 1. LF UK v Praze ; Přednosta: prof. MUDr. Karel Pavelka, DrSc. ; Revmatologický ústav Praha
Published in the journal: Prakt. Lék. 2020; 100(3): 143-148
Category: Of different specialties

Summary

Back pain is a very common problem in general population. Most common is simple low back pain, that is self-limited and does not require further investigation. Approximately 5% of cases may have inflammatory back pain (IBP), that is hallmark of axial spondylarthritis (axSpA). axSpA is a chronic progressive inflammatory disease. The disease typically develops in young adulthood, leads to permanent spine changes with hypomobility and impairs quality of life if misdiagnosed. The key factor for first line medical doctor is to identify individuals with suspicion on axSpA and refer them for further specialised rheumatology examination. IBP is main symptom that helps to reveal patients with axSpA, helpful may also be HLA-B27 positivity. Several reference strategies have been established to help early diagnosis of axSpA. Only early diagnosis and adequate treatment leads to inhibition of the inflammatory process and prevents permanent spine changes.

Keywords:

ankylosing spondylitis – axial spondyloarthritis – inflammatory back pain – non-radiographic axial spondyloarthritis – HLA-B27 antigen

Zdroje

1. Deodhar A, Strand V, Kay J, Braun J. The term ‚non-radiographic axial spondyloarthritis’ is much more important to classify than to diagnose patients with axial spondyloartrhtitis. Ann Rheum Dis 2016; 75(5): 791–794.

2. Deyo RA, Mirza SK, Martin BI. Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine (Phila Pa 1976) 2006; 31(23): 2724–2727.

3. Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001; 344(5): 363–370.

4. Imboden JB, Hellmann DB, Stone JH, et al. Current Diagnosis and Treatment: Rheumatology, 3^rd edition. New York: McGraw-Hill Medical 2013.

5. Khan MA. HLA-B27 and its subtypes in world population. Curr Opin Rheumatol 1995; 7(4): 263–269.

6. Papageorgiou AC, Croft PR, Ferry S, et al. Estimating the prevalence of low back pain in the general population. Evidence from the South Manchester Back Pain Survey. Spine (Phila Pa 1976) 1995; 20(17): 1889–1894.

7. Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 2006; 54(2): 569–578.

8. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validization and final selection. Ann Rheum Dis. 2009; 68(6): 777–783.

9. Sieper J, Rudwaleit M. Early referral recommendation for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis 2005; 64(5): 659–663.

10. Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009; 68(Suppl 2): ii1–ii44.

11. Sieper J, van der Heijde D, Landewé M, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patients exercise by experts from the Assessment of Spondyloarthritis international society (ASAS). Ann Rheum Dis 2009; 68(6): 784–788.

12. Šenolt L, Mann H, Herle P. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře. Revmatologie. Společnost všeobecného lékařství ČLS JEP, Centrum doporučených postupů pro praktické lékaře 2014.

13. West SG. Rheumatology secrets. New York: Elsevier 2015.

14. Zeidler H, Amor B. The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress. Ann Rheum Dis 2011; 70(1): 1–3.